Enanta Pharmaceuticals (ENTA) Interest Coverage Ratio (QoQ) (2013 - 2026)
Powered by 
Analysis
Enanta Pharmaceuticals (ENTA) Interest Coverage Ratio (QoQ) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn |
| 10 | Enanta Pharmaceuticals | 404.93 Mn | 215.43 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -16.76% |
| Mar 31, 2026 | 2.08% |
| Dec 31, 2025 | 52.61% |
| Sep 30, 2025 | 34.04% |
| Jun 30, 2025 | 18.40% |
| Mar 31, 2025 | -19.25% |
| Dec 31, 2024 | -3.74% |
| Sep 30, 2024 | -12.63% |
| Jun 30, 2024 | 19.67% |
| Mar 31, 2024 | -26.10% |
| Dec 31, 2023 | -2.95% |
| Sep 30, 2023 | 46.43% |
| Dec 31, 2017 | -73.52% |
| Sep 30, 2017 | 605.45% |
| Jun 30, 2017 | -0.45% |
| Mar 31, 2017 | -102.37% |
| Dec 31, 2016 | -108.42% |
| Sep 30, 2016 | -184.57% |
| Jun 30, 2016 | -92.74% |
| Mar 31, 2016 | -101.73% |